A Multi-center Study for Eradication of Helicobacter Pylori With Triple Therapy Using Clarithromycin

NAUnknownINTERVENTIONAL
Enrollment

672

Participants

Timeline

Start Date

January 31, 2017

Primary Completion Date

December 31, 2019

Study Completion Date

December 31, 2019

Conditions
Gastritis
Interventions
DEVICE

The results of clarithromycin susceptibility test of H. pylori isolates

According to the results of antibiotic susceptible testing, patients who were resistant to clarithromycin were belonged into clarithromycin resistance group.Patients who were sensitive to clarithromycin were belonged into the 7days/10days/14days treatment groups.

DEVICE

Computer generated random number, randomly assigned into groups

The patients with clarithromycin sensitive. Computer generated random number,randomly assigned into 7days/10days/14days treatment groups.

DEVICE

The result of 13C-urea breath test of patient in 7days/10days/14days treatment groups

The intervention focused on the results from the result of 13C-urea breath test at 8 weeks after treatment in patients. All patients were taking 75mg 13C-urea and analysis with a modified isotope ratio mass spectrometer to determine the 13CO2 content.The successful treatment groups were patients with negative in 13C-urea breath tests.The failed treatment of H. pylori groups were patients with positive in 13C-urea breath tests after the standardized triple therapy treatment.

Trial Locations (1)

317199

RECRUITING

Sanmen People's hospital, Taizhou

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Wenzhou Central Hospital

OTHER

collaborator

The First Affiliated Hospital with Nanjing Medical University

OTHER

collaborator

Taizhou Hospital

OTHER

collaborator

Affiliated Wenling Hospital of Wenzhou Medical University

OTHER

collaborator

Hangzhou Medical College

OTHER

collaborator

Centers for Disease Control and Prevention, China

OTHER_GOV

collaborator

Zhiyuan Medical Inspection Institute

OTHER

lead

Sanmen People's Hospital

OTHER

NCT02923856 - A Multi-center Study for Eradication of Helicobacter Pylori With Triple Therapy Using Clarithromycin | Biotech Hunter | Biotech Hunter